Invention Grant
- Patent Title: Methylphenidate extended release chewable tablet
-
Application No.: US16700517Application Date: 2019-12-02
-
Publication No.: US10857143B2Publication Date: 2020-12-08
- Inventor: Yu-Hsing Tu , Ashok Perumal , Kalyan Kathala
- Applicant: Tris Pharma, Inc.
- Applicant Address: US NJ Monmouth Junction
- Assignee: TRIS PHARMA, INC
- Current Assignee: TRIS PHARMA, INC
- Current Assignee Address: US NJ Monmouth Junction
- Agency: Howson & Howson
- Agent Cathy A. Kodroff
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K31/4458 ; A61K9/00 ; A61K9/28 ; A61K9/24 ; A61K47/58 ; A61K9/50

Abstract:
An oral methylphenidate extended release tablet is described, which can be scored and still retain its extended release profile. The tablet contains a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and an uncomplexed methylphenidate active component. Following administration of a single dose of the extended release methylphenidate chewable tablet, a therapeutically effective amount of methylphenidate is reached in less than about 20 minutes and the composition provides a twelve-hour extended release profile.
Public/Granted literature
- US1296503A Diaphragm-pump. Public/Granted day:1919-03-04
Information query